FN1 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC) cells, Erybraedin A inhibits cell adhesion to fibronectin via the inactivation of the protein tyrosine kinase Src and its interaction with β1 or β3 integrins, leading to cell death by anoïkis [28].